Our oncolytic cancer vaccine treatment induced a modest downregulation of the CD4+ T cells in both treated and untreated tumors (Figure 8—figure supplement 1C) in line with the increase of CD8+ T cells as mentioned before. Here, CD8A is linked to cancer.